The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.

@article{Oliveira2013TheEW,
  title={The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.},
  author={Jos{\'e} Lu{\'i}s Oliveira and Pedro Lopes and Tiago Nunes and David Campos and Scott Boyer and Ernst Ahlberg and Erik van Mulligen and Jan A. Kors and Bharat Singh and Laura In{\'e}s Furlong and Ferran Sanz and Anna Bauer-Mehren and Mar{\'i}a del Carmen Carrascosa and Jordi Mestres and Paul Avillach and Gayo Diallo and Carlos D{\'i}az Acedo and Johan van der Lei},
  journal={Pharmacoepidemiology and drug safety},
  year={2013},
  volume={22 5},
  pages={459-67}
}
PURPOSE Pharmacovigilance methods have advanced greatly during the last decades, making post-market drug assessment an essential drug evaluation component. These methods mainly rely on the use of spontaneous reporting systems and health information databases to collect expertise from huge amounts of real-world reports. The EU-ADR Web Platform was built to further facilitate accessing, monitoring and exploring these data, enabling an in-depth analysis of adverse drug reactions risks. METHODS… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Challenges and opportunities for exploring patient-level data: Preliminary results

2015 10th Iberian Conference on Information Systems and Technologies (CISTI) • 2015
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 45 references

The Association of French PharmacoVigilance C

A Sommet, G Durrieu, M Lapeyre-Mestre, J-L Montastruc
2012

Similar Papers

Loading similar papers…